EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer. (Q46039810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

Eastern Cooperative Oncology Group

28 December 2019

author

9

object named as

Eastern Cooperative Oncology Group

1 reference

18 December 2017

Sarita Dubey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Patricia Stephenson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Donna E Levy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Judith A Miller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Steven M Keller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Joan H Schiller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

David H Johnson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jill M Kolesar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Eastern Cooperative Oncology Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thoracic Oncology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

406-412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Epidermal growth factor receptor family in lung cancer and premalignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

A strong intronic enhancer element of the EGFR gene is preferentially active in high EGFR expressing breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro alpha 2 (I) collagen (COL1A2)

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931603-8

7 January 2021

10.1016/S1556-0864(15)31603-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409891%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference